Skip to content

TRANS-ID tapering : Transitions In Depressive symptoms during tapering of antidepressants

TRANS-ID tapering : Transitions In Depressive symptoms during tapering of antidepressants - TRANS-ID tapering

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
NL-OMON
Registry ID
NL-OMON45304
Enrollment
45
Registered
2017-05-03
Start date
2017-07-04
Completion date
Unknown
Last updated
2024-02-28

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Depressive symptoms feeling down mood transitions

Interventions

complex dynamic systems
depression

Sponsors

Universitair Medisch Centrum Groningen
Lead Sponsor

Eligibility

Age
18 Years to 64 Years

Inclusion criteria

Inclusion criteria: - age >= 18 - fulfil the criteria of a past depressive episode according to DSM-IV criteria - having made a shared decision with a mental health care provider (general practitioner, psychiatrist or a mental health care provider that is supervised by a general practitioner or psychiatrist) to taper the current dose of antidepressant medication - having made a tapering scheme or plan with a mental health care provider

Exclusion criteria

Exclusion criteria: - current depressive episode according to the DSM-IV criteria - presence of bipolar disorder or a psychotic disorder - reported diagnosis of a personality disorder - start of any other antidepressant treatment - inability to work with a smartphone - not giving informed consent on checking the tapering scheme or plan with the mental health care provider

Design outcomes

Primary

MeasureTime frame
The main study parameter is a within-person critical transition towards higher levels of depressive symptoms.

Secondary

MeasureTime frame
Secundary study parameters are daily affect, behavior, context, Heart Rate Variability, and physical activity.

Countries

The Netherlands

Outcome results

None listed

Source: NL-OMON (via WHO ICTRP)